Francesca Kolitsopoulos

Senior Director, Head of Oncology RWE Safety
Gilead Sciences Inc

Poster(s):

• (B-230) Optimizing the Identification and Classification of Non-Small Cell Lung Cancer (NSCLC): Validation and Implementation of a Patient Cohort Algorithm in Claims Databases
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-030) Use of Real-World Evidence to Satisfy U.S. FDA Postmarketing Requirements and Commitments
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET